Robert J, Osto E, von Eckardstein A (2021)
The Endothelium Is Both a Target and a Barrier of HDL's Protective Functions
Cells 10:
Session AM, Uno Y, Kwon T, Chapman JA, Toyoda A, Takahashi S, Fukui A, Hikosaka A, Suzuki A, Kondo M, van Heeringen SJ, Quigley I, Heinz S, Ogino H, Ochi H, Hellsten U, Lyons JB, Simakov O, Putnam N, Stites J, Kuroki Y, Tanaka T, Michiue T, Watanabe M, Bogdanovic O, Lister R, Georgiou G, Paranjpe SS, van Kruijsbergen I, Shu S, Carlson J, Kinoshita T, Ohta Y, Mawaribuchi S, Jenkins J, Grimwood J, Schmutz J, Mitros T, Mozaffari SV, Suzuki Y, Haramoto Y, Yamamoto TS, Takagi C, Heald R, Miller K, Haudenschild C, Kitzman J, Nakayama T, Izutsu Y, Robert J, Fortriede J, Burns K, Lotay V, Karimi K, Yasuoka Y, Dichmann DS, Flajnik MF, Houston DW, Shendure J, DuPasquier L, Vize PD, Zorn AM, Ito M, Marcotte EM, Wallingford JB, Ito Y, Asashima M, Ueno N, Matsuda Y, Veenstra GJ, Fujiyama A, Harland RM, Taira M, Rokhsar DS (2016)
Genome evolution in the allotetraploid frog Xenopus laevis
Nature 538: 336
Hellsten U, Harland RM, Gilchrist MJ, Hendrix D, Jurka J, Kapitonov V, Ovcharenko I, Putnam NH, Shu S, Taher L, Blitz IL, Blumberg B, Dichmann DS, Dubchak I, Amaya E, Detter JC, Fletcher R, Gerhard DS, Goodstein D, Graves T, Grigoriev IV, Grimwood J, Kawashima T, Lindquist E, Lucas SM, Mead PE, Mitros T, Ogino H, Ohta Y, Poliakov AV, Pollet N, Robert J, Salamov A, Sater AK, Schmutz J, Terry A, Vize PD, Warren WC, Wells D, Wills A, Wilson RK, Zimmerman LB, Zorn AM, Grainger R, Grammer T, Khokha MK, Richardson PM, Rokhsar DS (2010)
The genome of the Western clawed frog Xenopus tropicalis
Science 328: 633
Holmes RS, Wright MW, Laulederkind SJ, Cox LA, Hosokawa M, Imai T, Ishibashi S, Lehner R, Miyazaki M, Perkins EJ, Potter PM, Redinbo MR, Robert J, Satoh T, Yamashita T, Yan B, Yokoi T, Zechner R, Maltais LJ (2010)
Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins
Mamm Genome 21: 427
Bellott R, Le Morvan V, Charasson V, Laurand A, Colotte M, Zanger UM, Klein K, Smith D, Bonnet J, Robert J (2008)
Functional study of the 830C>G polymorphism of the human carboxylesterase 2 gene
Cancer Chemother Pharmacol 61: 481
Charasson V, Bellott R, Meynard D, Longy M, Gorry P, Robert J (2004)
Pharmacogenetics of human carboxylesterase 2, an enzyme involved in the activation of irinotecan into SN-38
Clinical Pharmacology & Therapeutics 76: 528
Pavillard V, Charasson V, Laroche-Clary A, Soubeyran I, Robert J (2004)
Cellular parameters predictive of the clinical response of colorectal cancers to irinotecan. A preliminary study
Anticancer Research 24: 579
Dodds HM, Haaz MC, Riou JF, Robert J, Rivory LP (1998)
Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38
Journal of Pharmacology & Experimental Therapeutics 286: 578
Robert J, Rivory L (1998)
Pharmacology of irinotecan
Drugs Today (Barc) 34: 777
Haaz MC, Rivory LP, Riche C, Robert J (1997)
The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes. Differential hydrolysis for the lactone and carboxylate forms
Naunyn Schmiedebergs Arch Pharmacol 356: 257
Rivory LP, Bowles MR, Robert J, Pond SM (1996)
Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase
Biochemical Pharmacology 52: 1103
Rivory LP, Riou JF, Haaz MC, Sable S, Vuilhorgne M, Commercon A, Pond SM, Robert J (1996)
Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients
Cancer Research 56: 3689
Massarelli R, Yong TY, Froissart C, Robert J (1979)
Choline uptake and metabolism by nerve cell cultures
Prog Brain Res 49: 89
Yavin E, Robert J (1979)
Dynamics of phospholipids in cultured cells of neural origin
Biochemical Society Transactions 7: 341
Robert J, Rebel G, Mandel P, Yavin E (1978)
Polar head groups manipulation of phospholipids in cultured neuroblastoma cells
Life Sciences 22: 211